Prosperity Consulting Group’s GSK GSK Stock Holding History

Prosperity Consulting Group’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.64M	Buy	31,262 +8,527	+38%	+$451K	0.06%	195
2026 Q1	$1.25M	Buy	22,735 +241	+1%	+$13.1K	0.06%	211
2025 Q4	$1.1M	Sell	22,494 -892	-4%	-$41.6K	0.05%	240
2025 Q3	$1.01M	Buy	23,386 +478	+2%	+$18.7K	0.05%	247
2025 Q2	$880K	Sell	22,908 -574	-2%	-$21.9K	0.06%	247
2025 Q1	$910K	Sell	23,482 -1,188	-5%	-$43.5K	0.07%	235
2024 Q4	$834K	Buy	24,670 +724	+3%	+$26.1K	0.06%	252
2024 Q3	$979K	Buy	+23,946	New	+$980K	0.08%	231

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Prosperity Consulting Group's GSK Position: Q2 2026 in Review

Prosperity Consulting Group increased its GSK (GSK) stake by 38% in Q2 2026, buying an estimated $451K and bringing the position to 31,262 shares worth $1.64M. The position accounts for 0.06% of the portfolio, ranked #195.

Prosperity Consulting Group first reported a position in GSK in Q3 2024 and has held it in 8 quarters since. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Prosperity Consulting Group held 31,262 shares of GSK worth $1.64M as of Q2 2026.
Prosperity Consulting Group bought 8,527 GSK shares in Q2 2026, an estimated $451K.
GSK made up 0.06% of Prosperity Consulting Group's portfolio in Q2 2026, its #195 holding.
Prosperity Consulting Group first reported a position in GSK in Q3 2024 and has held it in 8 quarters since.
1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Prosperity Consulting Group's 13F filing for Q2 2026, filed 13 Aug 2026.